Detection of telomerase activity in cervical lesions by non-radioactive Telomeric Repeat Amplification Protocol (TRAP);Detección de la actividad de la telomerasa en lesiones cervicales, mediante el Protocolo de Amplificación de Repeticiones Teloméricas (PART) no radioactivo

Investigacion Clinica

Volumn 46, Issue 3, 2005, Pages 255-263

  Pinto Tang, Joanna ^a   Castro, Thaís ^a   Premoli, Gloria ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

Author keywords

Cancer; HPV; Telomerase; Tumoral marker

Indexed keywords

TELOMERASE;

ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; KERATINOCYTE; MORTALITY; NONHUMAN; PAPANICOLAOU TEST; PROGNOSIS; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; UTERINE CERVIX CANCER;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PAPILLOMAVIRUS INFECTIONS; TELOMERASE; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 24644475280     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Luque J, Herráez A. Texto Ilustrado de Biología Molecular e Ingeniería Genética: Conceptos, técnicas y aplicaciones en Ciencias de la Salud. España: Harcourt. 2001.
2. Blackburn E. Structure and function of telomeres. Nature. 1991; 350:569-573.
3. Marcand S, Brevet V, Mann C, Gilson E. Cell cycle restriction of telomere elongation. Curr Biol 2000; 10:487-490.
4. Kim N, Piatyszek M, Prowse K, Harley C, West M, Ho P, Coviello G, Wright W, Weinrich S, Shay J. Specific association of human telomerase activity with inmortal cells and cancer. Science 1994; 266:2011-2014.
5. Zhang X, Mar V, Harrington L. Robinson M. Telomere shortening and apoptosis in telomerasa-inhibited human tumor cells. Genes Dev 1999; 13:2388-2399.
6. Liu J. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J 1999; 13:2091-2104.
7. Kinoshita T, Shirasawa H, Shino Y, Moriya H, Desbarats L, Eilers M, Simizu B. Transactivation of prothymosin α and c-Myc promoters by human papillomavirus type 16 E6 protein. Virol 1997; 232:53-61.
8. Greider C. Telomerase activation: One step on the road to cancer? Trends genet 1999; 15:109-112.
9. Gewin L, Myers H, Kiyono T, Galloway D. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev 2004; 18:2269-2282.
10. Veldman T, Liu X, Yuan H, Schlegel R. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc. Natl. Acad. Sci USA 2003; 100:8211-8216.
11. Lv W, Zhang G, Sui L, Wang J. Study on the correlation between the different papillomavirus type and telomerase in cervical cancer. Int J Gynecol Pathol 2004; 23 (29:100-109.
12. Ly W, Zhang G, Sui L, Wang J. Study on the correlation between the different papillomavirus type and telomerase in cervical cancer. Zhonghua Liu Xing Bimg Xue Za Zhi 2003; 24:924-927.
13. Reesink-Peters N, Helder M, Wisman G, Knol A, Koopmans S, Schuuring E, Hollema H, de Vries E, de Jong S, van der Zee A. Detection of telomerase, its components, and human papilloma virus in cervical scraping as a tool for triage in woman with cervical dysplasia. J Clin Pathol. 2003; 56:31-35.
14. Bosh F, de Sanjose S. Human papillomavirus in cervical cancer. Curr Oncol Rep. 2002; 4:175-183.
15. Alonso P, Lazcano E, Hernández M. Cáncer Cervicouterino: Diagnóstico, prevención y control. México: Médica Panamericana. 2000.
16. Jenkis D. Diagnosing human papillomaviruses: recent advances. Curr Opin Infect Dis 2001; 14:53-62.
17. Mu X, Brien T, Roos J, Lowry C, McKenna B. Telomerase activity in bening and malignant cytologic fluids. Cancer 1999; 87:93-99.
18. Urquidi V, Tarin D, Goodison S. Role of telomerase in cell senescence and oncogenesis. Annu Rev Med 2000; 51:65-79.
19. Ngan H, Cheung A, Liu S, Liu K, Tsao S. Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening. Tumour Biol 2002; 23:87-92.
20. Sen S, Reddy V, Guleria R, Jain S, Kapila K, Singh N. Telomerase a potential molecular marker of lung and cervical cancer. Clin Chem Lab Med 2002; 40:994-1001.
21. Jarboe E, Thompson L, Heinz D, McGregor J, Shroyer K. Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Human Pathol 2004; 35:396-402.
22. Wright T, Cox J, Massad L, Twiggs L, Wilkinson E. 2201 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003; 189:295-304.
23. Kyo S, Takakura M, Kohama T, Inoue M. Telomerase activity in human endometrium. Cancer Res 1997; 57:610-614.
24. Rolf A, Schuller I, Fink U, Weber-Rolfs I. PCR: Clinical Diagnostics and Research. Germany: Verlag Berlin Heidelber. 1992.
25. Saiki R, Bugawan T, Horn G, Mullis K, Erlich H. Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes. Letters to Nature 1996; 324:163-166.
26. Karlsen F, Kalantri M, Jenkis A, Petterson E, Kristensen G, Holm R, Johansson B, Hagmal B. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol. 1996; 34:2095-2100.
27. Zazove P, Reed B, Gregoire L, Ferenczy A, Gorenflo D, Lancaster W. Low false- negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions. J Clin Microbiol 1998; 36:2708-2713.
28. Lapointe P. Reflections on cervical cancer. Eur J Gynaecol Oncol 2004; 25:671-672.
29. Zheng P, Iwasaka T, Zhang Z, Pater A, Sugimori, H. Telomerase activity in papanicolaou smear-negative exfoliated cervical cells and its association with lesions and oncogenic human papillomaviruses. Ginecologic Oncology. 2000; 77:394-8.
30. Pao C, Tseng C, Lin C, Yang F, Hor J, Yao D, Hsueh S. Differential expression of telomerase activity in human cervical intraepithelial neoplasia lesions. J Clin Oncol 1997; 15:1932-1937.
31. Reddy V, Khanna N, Jain S, Das B, Singh N. Telomerase-A molecular marker for cervical cancer screening. Int J Gynecol Cancer 2001; 11:100-106.
32. Wisman B, Jong S, Meersma J, Helder M, Hollema H, de Vries E, Keith N, van der Zee A. Telomerase in (pre)neoplasic cervical disease. Human Pathol 2000; 31:1304-1310.
33. Yashima K, Ashfaq R, Nowak K, Von Gruenigen V, Milchgrub S, Rathi A, Albores-Saavedra J, Shay J, Gazdar A. Telomerase activity and expression of its RNA component in cervical lesions. Cancer 1998; 82:1319-1326.
34. McMurray H, McCance D. Human papillomavirus type 16 E6 activites TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J Virol 2003; 77:9852-9861.
35. Leng B, Bian M, Sun A, Fan M, Chen Q. Telomerase activity in cervical carcinoma and cervical intraepithelial neoplasic and its correlation to classification of koilocytocis. Zhonghua Yi Xue Za Zhi 2002; 82:262-266.
36. Chen Y, Hunter D. Molecular Epidemiology of Cancer. CA Cancer J Clin 2005; 55:45-54.